SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crypto CAW is trending due to community enthusiasm around the "crow with knife" meme and its potential during this bull run. The community is focused on its multichain expansion and strong community, using "caw caw" as a rallying cry. Some users highlight its deflationary mechanisms and are encouraging others to add it to their watchlists.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending amid community debate about its technology and future prospects, with some users expressing skepticism about eVTOL capabilities and range limitations. Bullish investors are pointing to upcoming events like the California International Air Show and potential military contracts as catalysts for growth. A possible collaboration with Tesla has also surfaced as a point of discussion among investors.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community discusses potential catalysts including upcoming news, partnerships, and the possibility of a major exchange listing. Bullish sentiment is fueled by comparisons to early XRP and anticipation of the Zebec Super App launch. Many believe ZBCN is positioned for significant growth and real-world adoption within the evolving financial landscape.

Reactive Network is the first parallelized interoperability execution layer, utilising a new form of smart contract we call reactive smart contracts.   Reactive smart contracts are able to react to on-chain events autonomously and execute their own user defined logic to initiate new transactions. This allows a virtually limitless number of use cases to achieve fully decentralized on-chain automation.

Reactive Network

Reactive Network ($REACT) is trending amid community excitement around its cross-chain automation capabilities and the upcoming sunsetting of $PRQ, which some believe has been suppressing its price. The community is also anticipating new exchange listings and marketing campaigns, while highlighting its strong technology and staking rewards. Discussions include potential price targets and the belief that $REACT is an undervalued gem with significant long-term potential.

UTZ Brands, Inc. manufactures, markets, and distributes branded snacking products. It offers a broad range of salty snacks, including potato chips, pretzels, cheese, veggie, other snacks and pork skins. The firm’s brands include Utz, Zapp’s, Golden Flake, Good Health, Boulder Canyon and Hawaiian. The company was founded in 1921 and is headquartered in Hanover, PA.

Utz Brands Inc - Ordinary Shares - Class A

Utz Brands is trending as the community discusses its recent earnings report, which beat expectations and prompted raised guidance. Community members are debating the impact of insider selling and a Goldman Sachs downgrade on the stock's price action, while others express confidence in the company's long-term potential and recession-resistant snack products.

What is Chainlink? Chainlink is the industry-standard oracle platform bringing the capital markets onchain and powering the majority of decentralized finance (DeFi). Chainlink stands to benefit the most from emerging blockchain-industry trends, such as stablecoin adoption, real-world asset tokenization, and institutional adoption of blockchain technology. Chainlink is powered by the LINK token, which is used to pay for platform services and secure the network’s proper functioning. Chainlink leverages a novel fee model where offchain and onchain revenue from enterprise adoption is converted to LINK tokens and stored in a strategic Chainlink Reserve.   Chainlink is at the forefront of financial innovation and the global tokenization trend. Traditional financial institutions and infrastructures, such as Swift, DTCC, Euroclear, J.P. Morgan, Mastercard, Central Bank of Brazil, UBS, SBI, Fidelity International, ANZ,  and many others are adopting Chainlink as fundamental infrastructure as they move toward tokenizing trillions onchain. Demand for Chainlink has already generated hundreds of millions of dollars in revenue across a variety of traditional and decentralized use cases.   Chainlink is the only all-in-one platform that fulfills the requirements of any institutional blockchain use case. The Chainlink platform enables developers and institutions to access all the critical data, interoperability, compute, compliance, privacy, and legacy-system connectivity required for advanced blockchain applications that link the onchain and offchain worlds. Chainlink solves four fundamental problems for institutions interacting with tokenized assets:  The data problem. Tokenized assets need real-world information to be usable in transactions, such as market pricing, reference data, and proof of reserves data. Chainlink is the market leader in bringing real-world data onchain securely and accurately. The liquidity problem. Financial institutions need tokenized assets that can be securely accessed and moved across blockchain networks in order to maximize liquidity. Chainlink CCIP is the only cross-chain interoperability standard that securely connects any public or private blockchain, opening up global markets for tokenized assets. The synchronization problem. Tokenized assets must remain synchronized with legacy systems once issued across multiple chains. Chainlink is the only platform that offers reliable offchain data, system connectivity, and secure cross-chain interoperability, enabling a Unified Golden Record that stays with assets anywhere. The compliance problem. Regulated institutions require compliance enforcement capabilities such as identity verification (KYC), risk screening (AML), exploit protection, and asset-specific restrictions. The Chainlink Automated Compliance Engine extends existing financial infrastructure for identity and compliance data to blockchains and tokenized assets.  Since launch, the Chainlink standard has securely enabled tens of trillions in transaction value across dozens of blockchains and published tens of billions of verified messages onchain. Chainlink actively secures the large majority of DeFi protocols across different blockchains, with near total dominance on Ethereum. As a chain-agnostic platform with thousands of users across the world’s largest financial institutions and DeFi protocols, Chainlink accelerates the adoption of blockchain ecosystems and is used by tens of thousands of developers, including protocols such as Aave, GMX, Lido, and many more. How does Chainlink work? Chainlink is a set of open standards for onchain data, cross-chain interoperability, and offchain computation. The platform is powered by decentralized oracle networks (DONs), which are composed of independent oracle node operators that come to consensus over any arbitrary input to deliver highly secure and reliable data, computation, and value to its intended destination. Chainlink node operators include traditional Web2 telecommunication providers, leading data providers, and Web3 infrastructure providers such as Deutsche Telekom, Swisscom, Vodafone, and Infura.   The Chainlink data standard, including Data Feeds and Data Streams, is used to supply DeFi with financial market data; tokenized assets with proof of reserve (PoR), net asset value (NAV), assets under management (AUM); traditional institutions with identity and compliance data; and decentralized applications (dApps) with virtually any type of data point they need to function.  The Chainlink interoperability standard, powered by the Cross-Chain Interoperability Protocol (CCIP), enables data and value to move seamlessly across any public and private blockchain, as well as facilitates communication between blockchains and traditional systems, such as banks, governments, and enterprises. CCIP secures tens of billions of dollars in asset value and has enabled the transfer of billions of dollars in cross-chain value. The Chainlink compute standard, powered by the Chainlink Runtime Environment (CRE) enables developers to easily build an application that combines any data, any blockchain, any legacy systems, and computation into a unified application. With CRE, developers can easily adapt the application to support new connections without having to rewrite the app. What is the LINK token? LINK is the native token of the Chainlink Network, used for both payments and staking. Users can pay for Chainlink services in LINK tokens or in alternative assets (e.g., gas tokens) that are automatically converted into LINK via Payment Abstraction and stored in a strategic Chainlink Reserve. The Reserve is designed to support the long-term growth and sustainability of the Chainlink Network by accumulating LINK tokens using offchain revenue from large enterprises that are adopting the Chainlink standard and from onchain service usage, which has already generated hundreds of millions in revenue. Network service providers, such as node operators and LINK Stakers, also earn rewards in LINK tokens, which can be staked to support the cryptoeconomic security of the Chainlink Network.  The Chainlink platform supports a range of billing and payment models, including usage-based payments (e.g., subscription contracts and per-call models), revenue-sharing agreements (e.g., percentage of application revenue or recaptured MEV), Chainlink Build (i.e., a program where projects allocate a portion of their token supply), and Chainlink Scale (i.e., a program where blockchain ecosystems cover Chainlink service operating costs).  Chainlink Staking adds an additional layer of cryptoeconomic security to the Chainlink Network where LINK is staked (locked up) and can be slashed (forfeited) as a penalty if service providers fail to meet predefined performance requirements. Both node operators and community stakers play a critical role in supporting the reliability and integrity of the Chainlink Network.

ChainLink

Chainlink (LINK) is trending as the crypto community debates its current price action and future potential, with some expressing frustration over its inability to break resistance levels despite positive news and partnerships. Community members are discussing technical analysis, potential catalysts, and comparing LINK's performance to other cryptocurrencies. Broader discussions include the role of oracles, real-world asset tokenization, and the impact of macroeconomic factors on the crypto market.

Roundhill ETF Trust - Roundhill PLTR WeeklyPay ETF

PLTW is trending due to discussions surrounding its weekly distribution payouts and overall performance. Community members are comparing it to similar income-generating ETFs, highlighting both its price appreciation and consistent dividend payments. Some are speculating about its long-term potential as a steady income stream, while others discuss strategies for reinvesting dividends.

Investment Managers Series Trust II - Tradr 2X Long UPST Daily ETF

Tradr 2X Long UPST Daily ETF

Traders are actively discussing $UPSX, a 2x leveraged ETF for Upstart, with many highlighting it as a way to amplify potential gains from $UPST, especially amid anticipation of future rate cuts. The community is weighing the risks and rewards of using the ETF, with some expressing concerns about its correlation to the underlying stock and others seeing it as a potential high-reward play. Overall sentiment leans bullish, with some expecting a significant move if $UPST rebounds.

The Hershey Co. engages in the manufacture and marketing of chocolate, sweets, mints and confectionery products. The firm operates through the following segments: North America Confectionery, North America Salty Snacks and International. The North America Confectionery segment is responsible for the traditional chocolate and non-chocolate confectionery market position of the company, as well as its grocery and snacks market positions, in the United States and Canada. The North America Salty Snacks segment is responsible for the salty snack products in the United States. The International segment includes the combination of all other operating segments, including those geographic regions where the company operates outside of North America. Its brands include Hershey's, Reese's, and Kisses. The company was founded by Milton S. Hershey in 1894 and is headquartered in Hershey, PA.

Hershey Company

HSY is trending amid reports of a potential takeover by Mondelez, driving speculation and a notable price surge. While some traders are betting on a continued rise, others anticipate a pullback if the deal doesn't materialize, given concerns about high cocoa prices and potential market overvaluation.

Tenable Holdings, Inc. engages in the development of security software solutions. It offers Cyber Exposure which is a discipline for managing and measuring cybersecurity risk in the digital era. Its products include tenable.io, tenable.sc, tenable.ot, and nessus professional. The firm delivers solutions in the field of application security, cloud security, compliance, energy, finance, healthcare, and retail. The company was founded by John C. Huffard, Jr. and Renaud M. Deraison in 2002 and is headquartered in Columbia, MD.

Tenable Holdings Inc

Tenable Holdings is trending amid discussions of its potential as an AI protection acquisition target and overall cybersecurity sector dynamics. Community members are weighing the company's merits against competitors, with some expressing disappointment in its muted market response despite positive earnings, while others suggest it's a hidden gem. Additionally, recent analyst rating adjustments and price target updates are contributing to the ongoing conversation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are You Looking for a Top Momentum Pick? Why Roivant Sciences Ltd. (ROIV) is a Great Choice

Does Roivant Sciences Ltd. (ROIV) have what it takes to be a top stock pick for momentum investors? Let's find out.

Montes Archimedes Acquisition (ROIV) Surges 7.8%: Is This an Indication of Further Gains?

Montes Archimedes Acquisition (ROIV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Shares of Roivant (ROIV) jumped 9% on Wednesday after the company, along with Priovant Therapeutics, announced positive results from a late-stage trial evaluating Brepocitinib in dermatomyositis.Dermatomyositis is a multi-organ idiopathic inflammatory condition that affects approximately 50,000 adults in the U.S. and is characterized by debilitating muscle weakness and skin lesions. No targeted therapies are approved for the condition, and a majority of patients are treated with high-dose oral steroids.Once-daily oral Brepocitinib 30 mg demonstrated clinically meaningful and statistically significant improvement compared to placebo on the primary endpoint and all key secondary endpoints in the study, including measurements of skin disease, muscle disease, steroid-sparing effect, and rapidity of onset, the company said.On Stocktwits, retail sentiment around ROIV stock stayed within the ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.<figure class="image"><img style="aspect-ratio:619/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_17_at_2_05_09_PM_png_94ffd6f84d.webp" alt="ROIV's Sentiment Meter and Message Volume as of 2:05 p.m. ET on Sept. 17, 2025 | Source: Stocktwits" width="619" height="61"><figcaption>ROIV's Sentiment Meter and Message Volume as of 2:05 p.m. ET on Sept. 17, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed optimism that the stock would rally further to $17.<stembedurl>https://stocktwits.com/StockBraker/message/628947861</stembedurl>Another user also cheered the stock’s rally over the past few weeks.<stembedurl>https://stocktwits.com/bbbloo/message/628950392</stembedurl>The company stated that 30mg of Brepocitinib achieved a week 52 mean Total Improvement Score (TIS) of 46.5 compared to 31.2 for placebo. It added that more than two-thirds of patients receiving the Brepocitinib 30 mg dose experienced at least a moderate response, with a TIS equal to or greater than 40, and nearly half experienced a major response, with a TIS equal to or exceeding 60.Furthermore, 42% of Brepocitinib 30 mg patients were able to discontinue steroids altogether, compared to 23% for the placebo, while 62% achieved a steroid dose of 2.5 mg or less per day. The safety profile observed in the study was consistent with that of previous trials, the company stated.The company plans to file for approval of the drug with the U.S. Food and Drug Administration for the treatment of dermatomyositis in the first half of 2026.ROIV stock is up 31% this year and approximately 28% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/gm-in-talks-to-renew-jv-with-chinas-saic-report/chDGDTkRd6t">GM In Talks To Renew JV With China’s SAIC: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Roivant Sciences logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Roivant Stock Rises After Drug Achieves Goals In Late-Stage Study: Retail Sees Further Rally To $17

Once-daily oral Brepocitinib 30 mg demonstrated clinically meaningful and statistically significant improvement compared to placebo on the primary endpoint and all key secondary endpoints in the study, the company said. 

Equity

Once-daily oral Brepocitinib 30 mg demonstrated clinically meaningful and statistically significant improvement compared to placebo on the primary endpoint and all key secondary endpoints in the study, the company said. 


Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates

Montes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of +21.74% and -71.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Kura Oncology (KURA) Reports Q2 Loss, Lags Revenue Estimates

Kura Oncology (KURA) delivered earnings and revenue surprises of -600.00% and -89.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates

Rhythm Pharmaceuticals (RYTM) delivered earnings and revenue surprises of -13.64% and +11.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Should Invesco S&P MidCap 400 GARP ETF (GRPM) Be on Your Investing Radar?

Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Lags Revenue Estimates

Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates

Codexis (CDXS) Reports Q1 Loss, Misses Revenue Estimates

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.

Roivant Sciences Ltd

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

ROIV
Roivant Sciences Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ROIV News

ROIV Roivant Sciences Ltd